Market Research

Insulin Pump Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Best Price Guarantee Length Publisher Published Date SKU
from $4,850 181 Pages Fortune Business Insights Pvt. Ltd. May, 2024 FOB18820050
Best Price Guarantee
Price from $4,850
Length 181 Pages
Publisher Fortune Business Insights Pvt. Ltd.
Published Date May, 2024
SKU FOB18820050

Insulin Pump Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032



Growth Factors of Insulin Pump Market

The insulin pump request size was valued at USD 5.26 billion in 2023, and the request is now projected to grow from USD 6.08 billion in 2024 to USD 21.65 billion by 2032, flaunting a CAGR of17.2 during the cast period of 2023- 2032.

The COVID- 19 epidemic braked the insulin pump business growth. Factors responsible for this included defer in the analysis and remedy of diabetes and detention in the purchase of these pumps by means of cases at some point of this period. also, regulations assessed through the governments of colorful nations caused dislocations in the force of pumps and consumables throughout the COVID- 19 epidemic.

adding penetration of these pumps among humans laid low with diabetes in developing countries is encouraging business players to cognizance on RD of technologically superior wares and launch new wares in the request. These RD tasks had been followed via multitudinous scientific trials, displaying evidence of sustained development in glycemic control in type 2 diabetic victims on pump remedy in comparison to those on MDI remedy.

The growing analysis and treatment price of kind 2 diabetes has created call for for new remedy druthers for dealing with the complaint. Also, the growing insulin- dependence of type 2 diabetes victims and the shift of victims from MDI to pain-free and occasion treatments are boosting the income of those pumps.

Comprehensive Analysis of Insulin Pump request

On the premise of product kind, the request is segmented into pumps and consumables. The pumps phase led the business chance due to their growing relinquishment a number of the diabetic crowd in evolved transnational locales. These wares give several blessings over a couple of every day injections, nonstop glucose videotape display units, and other widgets. According to the top officers at Tandem, the global pump relinquishment among cases with type 1 diabetes will growth with penetration within theU.S. And transnational requests. On the base of complaint suggestion, the business is segmented into kind 1 diabetes and sort 2 diabetes.

The request in North America turned into worth USD 3.04 billion in 2023. The position ruled this enterprise due to the rollout of favorable compensation guidelines within theU.S. For insulin delivery widgets. For illustration, Medicare Parts A and B wrap tubeless and tubed pumps, independently, taking the affected person to pay utmost effective 20 of the total figure of the pump. In addition, the presence of clinical device associations, together with Tandem and Insulet within the vicinity may also help the request grow.

The crucial players inside the business play a vital part within the healthcare enterprise assuring business prospectus smash and placing business norms. These gamers encompass, Medtronic( Ireland), Tandem Diabetes Care,Inc.(U.S.), Ypsomed AG( Switzerland), Insulet Corporation(U.S.),F. Hoffmann- La Roche Ltd( Switzerland), CeQur Simplicity( Switzerland), Microtec Medical Ltd(U.K.), ViCentraB.V.( Netherlands), SOOIL DevelopmentsCo., Ltd( Korea), and EOFLOWCO.,LTD.( Korea) the bones request gamers offer a degree- gambling competitive outlook.

In January 2024, PharmaSens a Switzerland- primarily grounded clinical device business enterprise, submitted an software to are searching for an blessing from theU.S. FDA for its new insulin pump. The pot entered ISO 13485 instrument in November 2023.

Segmentation Table

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 17.2% from 2024-2032

Unit Value (USD billion)

Segmentation By Product Type

Pumps

- Tethered Pumps

- Patch Pumps

- Others

Consumables

By Disease Indication

Type 1 Diabetes

Type 2 Diabetes

By Distribution Channel

Hospital Pharmacy

Retail & Online Pharmacy

By Geography

North America (By Product Type, By Disease Indication, By Distribution Channel, and By Country)

- U.S. (By Disease Indication)

- Canada (By Disease Indication)

Europe (By Product Type, By Disease Indication, By Distribution Channel, and By Country)

- U.K. (By Disease Indication)

- Germany (By Disease Indication)

- France (By Disease Indication)

- Italy (By Disease Indication)

- Spain (By Disease Indication)

- Scandinavia (By Disease Indication)

- Rest of Europe (By Disease Indication)

Asia Pacific (By Product Type, By Disease Indication, By Distribution Channel, and By Country)

- China (By Disease Indication)

- Japan (By Disease Indication)

- India (By Disease Indication)

- Australia (By Disease Indication)

- Southeast Asia (By Disease Indication)

- Rest of Asia Pacific (By Disease Indication)

Latin America (By Product Type, By Disease Indication, By Distribution Channel, and By Country)

- Brazil (By Disease Indication)

- Mexico (By Disease Indication)

- Rest of Latin America (By Disease Indication)

Middle East & Africa (By Product Type, By Disease Indication, By Distribution Channel, and By Country)

- GCC (By Disease Indication)

- South Africa (By Disease Indication)

- Rest of MEA (By Disease Indication)


Please Note: It will take 5-6 business days to complete the report upon order confirmation.


1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Overview: Trends in Cosmeceuticals Market
4.2. Snapshot of Active Ingredients Used in Cosmeceuticals
4.3. New Product Launches, By Key Players
4.4. Key Industry Developments - Mergers, Acquisitions, and Partnerships
4.5. Impact of COVID-19 on the Global Cosmeceuticals Market
5. Global Cosmeceuticals Market Analysis, Insights and Forecast, 2019-2032
5.1. Market Analysis, Insights and Forecast – By Product Type
5.1.1. Skin Care
5.1.1.1. Anti-Ageing
5.1.1.2. Skin Whitening
5.1.1.3. Sun Protection
5.1.1.4. Professional Skincare
5.1.1.5. Anti-Acne
5.1.1.6. Others
5.1.2. Hair Care
5.1.2.1. Hair Growth
5.1.2.2. Anti-Dandruff
5.1.2.3. Others
5.1.3. Injectable
5.1.3.1. Botulinum Toxins
5.1.3.2. Dermal fillers
5.1.3.3. Others
5.1.4. Others
5.1.4.1. Lip Care
5.1.4.2. Tooth Whitening
5.1.4.3. Anti-Cellulite/Body Slimming Preparations
5.1.4.4. Oral Care
5.2. Market Analysis, Insights and Forecast – By Distribution Channel
5.2.1. Pharmacy/Drug Stores
5.2.2. Online stores
5.2.3. Others
5.3. Market Analysis, Insights and Forecast – By Region
5.3.1. North America
5.3.2. Europe
5.3.3. Asia Pacific
5.3.4. Latin America
5.3.5. Middle East & Africa
6. North America Cosmeceuticals Market Analysis, Insights and Forecast, 2019-2032
6.1. Market Analysis, Insights and Forecast – By Product Type
6.1.1. Skin Care
6.1.1.1. Anti-Ageing
6.1.1.2. Skin Whitening
6.1.1.3. Sun Protection
6.1.1.4. Professional Skincare
6.1.1.5. Anti-Acne
6.1.1.6. Others
6.1.2. Hair Care
6.1.2.1. Hair Growth
6.1.2.2. Anti-Dandruff
6.1.2.3. Others
6.1.3. Injectable
6.1.3.1. Botulinum Toxins
6.1.3.2. Dermal fillers
6.1.3.3. Others
6.1.4. Others
6.1.4.1. Lip Care
6.1.4.2. Tooth Whitening
6.1.4.3. Anti-Cellulite/Body Slimming Preparations
6.1.4.4. Oral Care
6.2. Market Analysis, Insights and Forecast – By Distribution Channel
6.2.1. Pharmacy/Drug Stores
6.2.2. Online stores
6.2.3. Others
6.3. Market Analysis, Insights and Forecast – By Country
6.3.1. U.S.
6.3.1.1. Product type
6.3.2. Canada
6.3.2.1. Product type
7. Europe Cosmeceuticals Market Analysis, Insights and Forecast, 2019-2032
7.1. Market Analysis, Insights and Forecast – By Product Type
7.1.1. Skin Care
7.1.1.1. Anti-Ageing
7.1.1.2. Skin Whitening
7.1.1.3. Sun Protection
7.1.1.4. Professional Skincare
7.1.1.5. Anti-Acne
7.1.1.6. Others
7.1.2. Hair Care
7.1.2.1. Hair Growth
7.1.2.2. Anti-Dandruff
7.1.2.3. Others
7.1.3. Injectable
7.1.3.1. Botulinum Toxins
7.1.3.2. Dermal fillers
7.1.3.3. Others
7.1.4. Others
7.1.4.1. Lip Care
7.1.4.2. Tooth Whitening
7.1.4.3. Anti-Cellulite/Body Slimming Preparations
7.1.4.4. Oral Care
7.2. Market Analysis, Insights and Forecast – By Distribution Channel
7.2.1. Pharmacy/Drug Stores
7.2.2. Online stores
7.2.3. Others
7.3. Market Analysis, Insights and Forecast – By Country/ Sub-region
7.3.1. U.K.
7.3.1.1. Product Type
7.3.2. Germany
7.3.2.1. Product Type
7.3.3. France
7.3.3.1. Product Type
7.3.4. Italy
7.3.4.1. Product Type
7.3.5. Spain
7.3.5.1. Product Type
7.3.6. Rest of Europe
7.3.6.1. Product Type
8. Asia Pacific Cosmeceuticals Market Analysis, Insights and Forecast, 2019-2032
8.1. Market Analysis, Insights and Forecast – By Product Type
8.1.1. Skin Care
8.1.1.1. Anti-Ageing
8.1.1.2. Skin Whitening
8.1.1.3. Sun Protection
8.1.1.4. Professional Skincare
8.1.1.5. Anti-Acne
8.1.1.6. Others
8.1.2. Hair Care
8.1.2.1. Hair Growth
8.1.2.2. Anti-Dandruff
8.1.2.3. Others
8.1.3. Injectable
8.1.3.1. Botulinum Toxins
8.1.3.2. Dermal fillers
8.1.3.3. Others
8.1.4. Others
8.1.4.1. Lip Care
8.1.4.2. Tooth Whitening
8.1.4.3. Anti-Cellulite/Body Slimming Preparations
8.1.4.4. Oral Care
8.2. Market Analysis, Insights and Forecast – By Distribution Channel
8.2.1. Pharmacy/Drug Stores
8.2.2. Online stores
8.2.3. Others
8.3. Market Analysis, Insights and Forecast – By Country/ Sub-region
8.3.1. China
8.3.1.1. Product Type
8.3.2. Japan
8.3.2.1. Product Type
8.3.3. India
8.3.3.1. Product Type
8.3.4. Australia
8.3.4.1. Product Type
8.3.5. Southeast Asia
8.3.5.1. Product Type
8.3.6. Rest of Asia Pacific
8.3.6.1. Product Type
9. Latin America Cosmeceuticals Market Analysis, Insights and Forecast, 2019-2032
9.1. Market Analysis, Insights and Forecast – By Product Type
9.1.1. Skin Care
9.1.1.1. Anti-Ageing
9.1.1.2. Skin Whitening
9.1.1.3. Sun Protection
9.1.1.4. Professional Skincare
9.1.1.5. Anti-Acne
9.1.1.6. Others
9.1.2. Hair Care
9.1.2.1. Hair Growth
9.1.2.2. Anti-Dandruff
9.1.2.3. Others
9.1.3. Injectable
9.1.3.1. Botulinum Toxins
9.1.3.2. Dermal fillers
9.1.3.3. Others
9.1.4. Others
9.1.4.1. Lip Care
9.1.4.2. Tooth Whitening
9.1.4.3. Anti-Cellulite/Body Slimming Preparations
9.1.4.4. Oral Care
9.2. Market Analysis, Insights and Forecast – By Distribution Channel
9.2.1. Pharmacy/Drug Stores
9.2.2. Online stores
9.2.3. Others
9.3. Market Analysis, Insights and Forecast – By Country/ Sub-region
9.3.1. Brazil
9.3.1.1. Product Type
9.3.2. Mexico
9.3.2.1. Product Type
9.3.3. Rest of Latin America
9.3.3.1. Product Type
10. Middle East & Africa Cosmeceuticals Market Analysis, Insights and Forecast, 2019-2032
10.1. Market Analysis, Insights and Forecast – By Product Type
10.1.1. Skin Care
10.1.1.1. Anti-Ageing
10.1.1.2. Skin Whitening
10.1.1.3. Sun Protection
10.1.1.4. Professional Skincare
10.1.1.5. Anti-Acne
10.1.1.6. Others
10.1.2. Hair Care
10.1.2.1. Hair Growth
10.1.2.2. Anti-Dandruff
10.1.2.3. Others
10.1.3. Injectable
10.1.3.1. Botulinum Toxins
10.1.3.2. Dermal fillers
10.1.3.3. Others
10.1.4. Others
10.1.4.1. Lip Care
10.1.4.2. Tooth Whitening
10.1.4.3. Anti-Cellulite/Body Slimming Preparations
10.1.4.4. Oral Care
10.2. Market Analysis, Insights and Forecast – By Distribution Channel
10.2.1. Pharmacy/Drug Stores
10.2.2. Online stores
10.2.3. Others
10.3. Market Analysis, Insights and Forecast – By Country/ Sub-region
10.3.1. GCC Countries
10.3.1.1. Product Type
10.3.2. South Africa
10.3.2.1. Product Type
10.3.3. Rest of Middle East & Africa
10.3.3.1. Product Type
11. Competitive Analysis
11.1. Global Market Share Analysis (2023)
11.2. Company Profiles
11.2.1. L’Oréal
11.2.1.1. Overview
11.2.1.2. Products & Services
11.2.1.3. SWOT Analysis
11.2.1.4. Recent Developments
11.2.1.5. Strategies
11.2.1.6. Financials (Based on Availability)
11.2.2. Estée Lauder Companies Inc.
11.2.2.1. Overview
11.2.2.2. Products & Services
11.2.2.3. SWOT Analysis
11.2.2.4. Recent Developments
11.2.2.5. Strategies
11.2.2.6. Financials (Based on Availability)
11.2.3. BEIERSDORF
11.2.3.1. Overview
11.2.3.2. Products & Services
11.2.3.3. SWOT Analysis
11.2.3.4. Recent Developments
11.2.3.5. Strategies
11.2.3.6. Financials (Based on Availability)
11.2.4. Shiseido Company Limited
11.2.4.1. Overview
11.2.4.2. Products & Services
11.2.4.3. SWOT Analysis
11.2.4.4. Recent Developments
11.2.4.5. Strategies
11.2.4.6. Financials (Based on Availability)
11.2.5. Procter and Gamble
11.2.5.1. Overview
11.2.5.2. Products & Services
11.2.5.3. SWOT Analysis
11.2.5.4. Recent Developments
11.2.5.5. Strategies
11.2.5.6. Financials (Based on Availability)
11.2.6. Elementis Plc
11.2.6.1. Overview
11.2.6.2. Products & Services
11.2.6.3. SWOT Analysis
11.2.6.4. Recent Developments
11.2.6.5. Strategies
11.2.6.6. Financials (Based on Availability)
11.2.7. Avon
11.2.7.1. Overview
11.2.7.2. Products & Services
11.2.7.3. SWOT Analysis
11.2.7.4. Recent Developments
11.2.7.5. Strategies
11.2.7.6. Financials (Based on Availability)
11.2.8. Allergan
11.2.8.1. Overview
11.2.8.2. Products & Services
11.2.8.3. SWOT Analysis
11.2.8.4. Recent Developments
11.2.8.5. Strategies
11.2.8.6. Financials (Based on Availability)
11.2.9. BASF SE
11.2.9.1. Overview
11.2.9.2. Products & Services
11.2.9.3. SWOT Analysis
11.2.9.4. Recent Developments
11.2.9.5. Strategies
11.2.9.6. Financials (Based on Availability)
11.2.10. Croda International Plc
11.2.10.1. Overview
11.2.10.2. Products & Services
11.2.10.3. SWOT Analysis
11.2.10.4. Recent Developments
11.2.10.5. Strategies
11.2.10.6. Financials (Based on Availability)
11.2.11. Unilever
11.2.11.1. Overview
11.2.11.2. Products & Services
11.2.11.3. SWOT Analysis
11.2.11.4. Recent Developments
11.2.11.5. Strategies
11.2.11.6. Financials (Based on Availability)
11.2.12. Coty Inc.
11.2.12.1. Overview
11.2.12.2. Products & Services
11.2.12.3. SWOT Analysis
11.2.12.4. Recent Developments
11.2.12.5. Strategies
11.2.12.6. Financials (Based on Availability)
11.2.13. Johnson & Johnson Services, Inc.
11.2.13.1. Overview
11.2.13.2. Products & Services
11.2.13.3. SWOT Analysis
11.2.13.4. Recent Developments
11.2.13.5. Strategies
11.2.13.6. Financials (Based on Availability)
11.2.14. Clarins
11.2.14.1. Overview
11.2.14.2. Products & Services
11.2.14.3. SWOT Analysis
11.2.14.4. Recent Developments
11.2.14.5. Strategies
11.2.14.6. Financials (Based on Availability)
11.2.15. LVMH
11.2.15.1. Overview
11.2.15.2. Products & Services
11.2.15.3. SWOT Analysis
11.2.15.4. Recent Developments
11.2.15.5. Strategies
11.2.15.6. Financials (Based on Availability)

$4,850
$6,850

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings